These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25003310)

  • 1. Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia.
    Tardy M; Dold M; Engel RR; Leucht S
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD009396. PubMed ID: 25003310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia.
    Tardy M; Huhn M; Kissling W; Engel RR; Leucht S
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD009268. PubMed ID: 25007358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia.
    Tardy M; Huhn M; Engel RR; Leucht S
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009230. PubMed ID: 25087165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia.
    Tardy M; Huhn M; Engel RR; Leucht S
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD009369. PubMed ID: 25290157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders.
    Dold M; Samara MT; Li C; Tardy M; Leucht S
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD009831. PubMed ID: 25592299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance treatment with antipsychotic drugs for schizophrenia.
    Ceraso A; Lin JJ; Schneider-Thoma J; Siafis S; Tardy M; Komossa K; Heres S; Kissling W; Davis JM; Leucht S
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD008016. PubMed ID: 32840872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trifluoperazine versus placebo for schizophrenia.
    Koch K; Mansi K; Haynes E; Adams CE; Sampson S; Furtado VA
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD010226. PubMed ID: 24414883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quetiapine versus typical antipsychotic medications for schizophrenia.
    Suttajit S; Srisurapanont M; Xia J; Suttajit S; Maneeton B; Maneeton N
    Cochrane Database Syst Rev; 2013 May; (5):CD007815. PubMed ID: 23728667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risperidone (depot) for schizophrenia.
    Sampson S; Hosalli P; Furtado VA; Davis JM
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD004161. PubMed ID: 27078222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia.
    Barber S; Olotu U; Corsi M; Cipriani A
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD006324. PubMed ID: 28333365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trifluoperazine for schizophrenia.
    Marques LO; Lima MS; Soares BG
    Cochrane Database Syst Rev; 2004; 2004(1):CD003545. PubMed ID: 14974020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zuclopenthixol dihydrochloride for schizophrenia.
    Bryan EJ; Purcell MA; Kumar A
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD005474. PubMed ID: 29144549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlorpromazine versus atypical antipsychotic drugs for schizophrenia.
    Saha KB; Bo L; Zhao S; Xia J; Sampson S; Zaman RU
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD010631. PubMed ID: 27045703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Schwarz S; Schmid F; Hunger H; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2011 Jan; (1):CD006626. PubMed ID: 21249678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse.
    Temmingh HS; Williams T; Siegfried N; Stein DJ
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011057. PubMed ID: 29355909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium for schizophrenia.
    Leucht S; Helfer B; Dold M; Kissling W; McGrath JJ
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD003834. PubMed ID: 26509923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Duggan L; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Mar; (3):CD006654. PubMed ID: 20238348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wendan decoction (Traditional Chinese medicine) for schizophrenia.
    Deng H; Xu J
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD012217. PubMed ID: 28657646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance treatment with antipsychotic drugs for schizophrenia.
    Leucht S; Tardy M; Komossa K; Heres S; Kissling W; Davis JM
    Cochrane Database Syst Rev; 2012 May; (5):CD008016. PubMed ID: 22592725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.